NDC 71335-0236 – Zaleplon

Zaleplon 5 mg/1 · Capsule · Oral

Human Prescription Drug DEA schedule CIV

Product NDC71335-0236

Product details

Brand name
Zaleplon
Generic name
Zaleplon
Labeler
Bryant Ranch Prepack
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA078989
Marketed since
May 5, 2009
Listing expires
December 31, 2026
Pharmacologic class
gamma-Aminobutyric Acid A Receptor Agonist

Active ingredients

Uses, dosage, side effects and warnings for Zaleplon →

Package NDC codes (5)

Package NDCDescriptionSince
71335-0236-130 CAPSULE in 1 BOTTLE (71335-0236-1)May 8, 2019
71335-0236-260 CAPSULE in 1 BOTTLE (71335-0236-2)Mar 23, 2018
71335-0236-390 CAPSULE in 1 BOTTLE (71335-0236-3)Dec 27, 2021
71335-0236-420 CAPSULE in 1 BOTTLE (71335-0236-4)Dec 27, 2021
71335-0236-528 CAPSULE in 1 BOTTLE (71335-0236-5)Dec 27, 2021

Other Zaleplon products